City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation

Border Border
The following is a list of available studies directed by  Auayporn Nademanee, MD  
Search results:  3  Clinical trial(s) found  (Page 1 of 1 )
Results per page: 25 50 100 All 1-3 Trials Jump to page:

COH Protocol Number: 14109 Number: NCT01974440

Principal Investigator: Auayporn Nademanee, MD
Sponsor: Industrial

Title:  A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Bruton's Tyrosine Kinase Inhibitor, PCI-32765 (Ibrutinib), in Combination with Either Bendamustine and Rituximab (BR) or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Subjects with Previously Treated Indolent Non-Hodgkin Lymphoma (iNHL)

COH Protocol Number: 05149 Number: NCT00577278

Principal Investigator: Auayporn Nademanee, MD
Sponsor: NCI Approved External Peer Review

Title:  A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for B–Cell Non–Hodgkin Lymphoma Using Zevalin®, Fludarabine and Melphalan

COH Protocol Number: 02149

Principal Investigator: Auayporn Nademanee, MD
Sponsor: Institutional

Title:  NMDP 2002-0063: Research Database for Hematopoietic Stem Cell Transplantation and Marrow Toxic Injuries

Results per page: 25 50 100 All 1-3 Trials Jump to page:

NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and gynecology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.